Navigation Links
Rigel's R788 Phase 2a Results Published in Arthritis and Rheumatism
Date:11/11/2008

officer of Rigel. Results from both studies are expected to be available in late summer 2009.

TASKi2 will evaluate RA patients receiving 100 mg of R788 orally, twice a day or 150 mg once a day, compared with those receiving placebo in a multi- center, randomized, double blind, placebo controlled parallel dose study of RA patients who have failed to respond to methotrexate. TASKi2 will enroll 420 patients (all of whom have been identified) to receive study drug or placebo, along with their steady dose of methotrexate, over a 6 month treatment period.

TASKi3 will evaluate RA patients receiving 100 mg of R788 orally, twice a day, compared with those receiving placebo in a multi-center, randomized, double blind, placebo controlled, parallel dose study of R788 in patients who have failed at least one marketed biologic agent (i.e., anti-TNF injectibles commonly used to treat RA). Approximately 195 patients are expected to be enrolled in TASKi3. Each will receive R788 or placebo over a 3 month treatment period.

For more information about the TASKi studies and R788's mechanism of action in RA and other autoimmune disorders, please visit the company's website.

About Rigel (http://www.Rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

This press release contains "forward-looking" statements, inc
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
2. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
3. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
4. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
5. Patient Recruitment Begins in India for Phase 3 Diabetes Trial
6. Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
7. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
8. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
9. VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
10. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
11. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)...  BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company ... to address unmet needs in large, well-defined and underserved ... executive officer and co-founder of BioPharmX, will present at ... on Wednesday, March 11 at 9:00 a.m. PDT at ... Dana Point , California.   ...
(Date:3/3/2015)... , March 3, 2015  UnaliWear announces the market ... support for seniors that guards against wandering and provides ... The new wearable – the Kanega watch ( http://www.UnaliWear.com ... to use an easy speech interface rather than buttons, ... without human input. The watch goes ...
(Date:3/3/2015)... -- American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ) a ... in the design, development and production of innovative ... device companies has announced the acquisition of MTI ... cable manufacturer based in North Carolina.  The new ... name MTI Medical Cables.  The ...
Breaking Medicine Technology:BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2American Biosurgical Acquires MTI Corporation 2
... 2011 Cardica, Inc. (Nasdaq: CRDC ) today ... 30, 2011. Cardica,s management will host a conference call at ... and provide an update on the company,s business. ... Dr. Swanstrom, a world-renowned key opinion leader in laparoscopic surgery, ...
... ($ in millions, except per share data, unaudited)ItemQ3 2011Q3 ... Net Product Revenue , $112.9 , 16.9% increaseNaglazyme Net ... Product Revenue* , $23.0 , $16.5Kuvan Net Product ... , $3.5 , 59.1% increaseGAAP Net Income (Loss) , ...
Cached Medicine Technology:Cardica Announces Fiscal 2012 First Quarter Financial Results 2Cardica Announces Fiscal 2012 First Quarter Financial Results 3Cardica Announces Fiscal 2012 First Quarter Financial Results 4Cardica Announces Fiscal 2012 First Quarter Financial Results 5Cardica Announces Fiscal 2012 First Quarter Financial Results 6BioMarin Announces Third Quarter 2011 Financial Results 2BioMarin Announces Third Quarter 2011 Financial Results 3BioMarin Announces Third Quarter 2011 Financial Results 4BioMarin Announces Third Quarter 2011 Financial Results 5BioMarin Announces Third Quarter 2011 Financial Results 6BioMarin Announces Third Quarter 2011 Financial Results 7BioMarin Announces Third Quarter 2011 Financial Results 8BioMarin Announces Third Quarter 2011 Financial Results 9BioMarin Announces Third Quarter 2011 Financial Results 10BioMarin Announces Third Quarter 2011 Financial Results 11BioMarin Announces Third Quarter 2011 Financial Results 12BioMarin Announces Third Quarter 2011 Financial Results 13
(Date:3/3/2015)... March 3, 2015, My Positive Perspective host ... episode was a unique one, not just because it was ... featured two men who were both faced with monumental obstacles ... of the episode, Deierlein said to Collins, “I had the ... but I’m very excited that you could join me on ...
(Date:3/3/2015)... March 03, 2015 eMedEvents, a ... continuing medical education (CME) credit information, has officially ... doctors was initially launched in the United States ... its kind in the field of healthcare conference ... of this Denver, Colorado-based start-up company was successful ...
(Date:3/3/2015)... Jack Coats, Chief Executive Officer of ... has been named to the company’s Board of Directors. ... fully integrated version of its Multiparametric Strain Analysis Software ... motion of the heart that is acquired from cardiac ... points to the motion of a normal heart model. ...
(Date:3/3/2015)... 03, 2015 Ticket Down is a reputable ... 2015 tour. This well-known ticket exchange is offering their ... the biggest name in the music business will tour around ... the “Rebel Heart Tour.” Madonna, fresh off a memorable performance ... her latest tour on August 29th in Miami, FL at ...
(Date:3/3/2015)... Chicago has long been known as a premier location ... level of basketball to Chicago that the world had never ... Chicago Bulls days in the 1990’s. His brilliance created a ... era also witnessed the birth and rise of Nike Basketball ... basketball culture, US Sports Camps seeks to meet an exceedingly ...
Breaking Medicine News(10 mins):Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:eMedEvents Launches Online Medical Conference, Speaker and CME Platform in India 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 3Health News:Cheap Madonna Tickets: Madonna Presale Tickets in Miami, New York, Brooklyn, Chicago, San Jose, Toronto, Edmonton & Vancouver Now Available at TicketDown.com 2Health News:Cheap Madonna Tickets: Madonna Presale Tickets in Miami, New York, Brooklyn, Chicago, San Jose, Toronto, Edmonton & Vancouver Now Available at TicketDown.com 3Health News:US Sports Camps and Nike Basketball Camps Add Five New Locations In and Around Chicago for the Summer of 2015 2
... Million in Total Revenues for the QuarterSAN DIEGO, April 29 /PRNewswire-FirstCall/ ... ), a real estate investment trust focused on Providing Real Estate ... for the first quarter ended March 31, 2009. Highlights: , ... Record total revenues for the first quarter were $94.0 million, ...
... hundred airport workers and supporters held a march and rally ... Wednesday, April 29. Worker anger over the lack of quality ... swine flu have mounted. Coalition members and service workers ... and marched through the Tom Bradley International Terminal.Workers say that ...
... -- Traumatic brain injury (TBI), a complex ... among Veterans and has been called one of the ... TBI is wide-ranging. Among its goals: shedding light on ... screening and diagnosis; developing drugs to treat brain injury ...
... Calif., April 29 Nektar Therapeutics (Nasdaq: NKTR ... ended March 31, 2009 on Wednesday, May 6, 2009, after ... chief executive officer, will host a conference call to review ... Pacific Time (PT). The press release and a live audio-only ...
... chances of a relapse or a deterioration of the condition, according ... London. , The results of a major trial presented at the ... that taking a course of cladribine tablets just a few times ... over 50 per cent. And patients who took part in the ...
... of a novel therapy that uses magnetic pulses to ... a promising alternative to medication. , The therapy is ... were presented today (April 29, 2009) during the annual ... , In a previous randomized controlled clinical study ...
Cached Medicine News:Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 2Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 3Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 4Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 5Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 6Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 7Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 8Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 9Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 10Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 11Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 12Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 13Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 14Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 15Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 16Health News:BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results 17Health News:Airport Workers March and Rally to Call for Family Healthcare as Swine Flu Fears Mount 2Health News:Video: Turning Hope Into Reality - Traumatic Brain Injury Research at the VA 2Health News:Nektar to Announce Financial Results for the First Quarter of 2009 on Wednesday, May 6, 2009, After Close of U.S.-Based Financial Markets 2Health News:New pill to treat MS 2Health News:New therapy based on magnetic stimulation shows promise for non-drug treatment for migraine 2
Foam Cervical Collar is medium-firm density. Breathable. Deeply anatomically contoured. Natural color, 100% cotton stockinette-covered for comfort. 2" hook and loop closures are another mark of quali...
... Ezy Wrap® Economy ... urethane foam with synthtic ... be reversed for flexion ... Hand wash, air dry. ...
... improves patient compliance, prevent skin breakdown ... user's anatomy, wicks moisture, and evenly ... shoulders and upper throacic. Fits upright ... airflow openings. Adjustable Occipital Support Strap™ ...
... stabilization for muscles and ligaments to aid ... discomfort. Strong elastic abdominal belt provides ... degrees of compression. Two semi-rigid metal ... support. Tapered in front for optimum ...
Medicine Products: